At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
myBluTM Formulation 1 +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Exploratory PET-study of Deposition, Disposition and Brain Uptake of [11C]Nicotine After Inhalation of 2 Nicotine Formulations Via the myBluTM E-cigarette in Smokers
In Brief
A clinical study evaluating myBluTM Formulation 1 and myBluTM Formulation 2 for Healthy Volunteers. Completed, enrolled 16 participants across 1 site.
Detailed Summary
This is a single-center, exploratory positron emission tomography (PET) study of deposition, disposition and brain uptake \[11C\]nicotine when given to smokers as two different formulations via mybluTM e-cigarette system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesSweden
CollaboratorsNerudia Ltd
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartMar 2020
Primary CompletionNov 2020
First PostedMar 2021
TodayJul 2026
First PostedMar 4, 2021
Enrollment StartMar 16, 2020
Primary CompletionNov 17, 2020
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.3 years ago
Interventions
myBluTM Formulation 1other
1-2 puffs of each 3-5 seconds duration taken from myBluTM with Formulation 1, with inhalation of the vapour into the lungs
myBluTM Formulation 2other
1-2 puffs of each 3-5 seconds duration taken from myBluTM with Formulation 2, with inhalation of the vapour into the lungs